All Categories
ERBITUX 100

ERBITUX 100

Helpful in the treatment of epidermal growth factor receptor and metastatic colorectal cancer as determined by the FDA-approved test. The recommended dose of this injectable solution is 2 mg/ml (50mL, 100 mL through single-use vials). The dose is for either monotherapy or in combination. For every patient, the dose typically varies and is decided by the condition of the patient by the top medical practitioner.

Manufacture : MERCK SHARP AND DOHME

Active Ingredient: CETUXIMAB 100

Packing : 1 VIAL

Related Products

FULVENAT

FULVENAT

Manufacture : NATCO PHARMA LTD

Fulvestrant is a generic medicine used to treat breast cancer that has spread to

ANADAY

ANADAY

Manufacture : ZUVENTUS (EMCURE) HEALTHCARE LTD

Generic medicine anastrozole lowers estrogen level in postmenopausal women where

VIVITRA 440

VIVITRA 440

Manufacture : Zydus Cadila

Transtuzumab antibodies are a relatively new type of cancer therapy.

Most Viewed

Blog

Blog2

Blog2

  • 08 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog1

Blog1

  • 26 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog

Blog

  • 09 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

FOLLOW US ON
© 2020 Universal Health Care and Suppliers. All Rights Reserved.